<div class="dropdown"><!-- [et_pb_line_break_holder] --> <button class="dropbtn">Select Language</button><!-- [et_pb_line_break_holder] --> <div class="dropdown-content"><!-- [et_pb_line_break_holder] --> <a href="https://www.thelondongeneralpractice.com/global-health-concierge-ar/">اللغة العربية</a><!-- [et_pb_line_break_holder] --> <a href="https://www.thelondongeneralpractice.com/global-health-concierge-zh/">中文普通话</a><!-- [et_pb_line_break_holder] --> <a href="https://www.thelondongeneralpractice.com/global-health-concierge-es/">Español</a><!-- [et_pb_line_break_holder] --><a href="https://www.thelondongeneralpractice.com/global-health-concierge-ru/">русский</a><!-- [et_pb_line_break_holder] --><a href="https://www.thelondongeneralpractice.com/healthcare-global-reach/">English</a><!-- [et_pb_line_break_holder] --> </div><!-- [et_pb_line_break_holder] --></div>
全球健康医疗 管家式服务
将从您最初的咨询开始，协调您所有的医疗需求，在整个治疗过程中提供保障。
我们公司总部位于伦敦著名的 Harley Street 大街，在洛杉矶、香港和迪拜设有分支机构。我们的目标是携手著名医生，向高净值客户和企业客户提供高端健康定制服务。
我们公司总部位于伦敦著名的 Harley Street 大街，在洛杉矶、香港和迪拜设有分支机构。我们的目标是携手著名医生，向高净值客户和企业客户提供高端健康定制服务。
一体化护理服务
如果因为工作的关系或在海外有房产，您和家人需要在出国生活一段时间，London General Practice 将可以帮助您联系全球各大城市最优秀的医生，随时为您提供服务。
我们的实力在美国（比如纽约、波士顿、洛杉矶和迈阿密）、香港和若干重要欧洲城市中尤其强大，这个网络还在不断发展壮大的过程之中，将纳入更多亚洲地区和澳洲地区的城市。
如需了解我们更多的服务信息或要与我们的 GP 进行咨询预约，欢迎致电 0207 935 1000
我们提供全天 24 小时家访服务，欢迎致电 +44 (0)207 935 1000.
Closed
Genetic Testing for Cancer
The panel determines whether you are at an increased risk to develop more than 57 inherited conditions, including:
- Breast cancer
- Colorectal (bowel) cancer
- Cutaneous melanoma
- Gastric cancer
- Ovarian cancer
- Pancreatic cancer
- Prostate cancer
- Renal cell cancer
- Thyroid cancer
- Uterine cancer
- Additional hereditary cancer conditions
The full list of genes tested for and their related condition is below:
| Gene(s) | Condition(s) | |
| APC | Colorectal, endocrine, gastric, nervous system/brain, and pancreatic cancer, sarcoma | |
| ATM | Breast, pancreatic, and prostate cancer | |
| AXIN2 | Colorectal cancer | |
| BAP1 | Renal/urinary tract cancer, melanoma | |
| BARD1 | Breast cancer | |
| BMPR1A | Colorectal, gastric, and pancreatic cancer | |
| BRCA1 | Breast, gynaecologic, pancreatic, and prostate cancer | |
| BRCA2 | Breast, gynaecologic, pancreatic, and prostate cancer, melanoma | |
| BRIP1 | Breast and gynaecologic cancer | |
| CDC73 | Endocrine and renal/urinary tract cancer | |
| CDH1 | Breast, colorectal, and gastric cancer | |
| CDK4 | Melanoma | |
| CDKN2A | Nervous system/brain and pancreatic cancer, melanoma | |
| CHEK2 | Breast, colorectal, endocrine, gynaecologic, and prostate cancer | |
| DICER1 | Endocrine, gynaecologic, nervous system/brain, and renal/ urinary tract cancer, sarcoma | |
| EPCAM | Colorectal, gastric, gynaecologic, nervous system/brain, pancreatic, prostate, and renal/urinary tract cancer | |
| FH | Renal/urinary tract cancer, sarcoma | |
| FLCN | Renal/urinary tract cancer | |
| GREM1 | Colorectal cancer | |
| HOXB13 | Prostate cancer | |
| KIT | Gastric cancer, sarcoma | |
| MAX | Endocrine cancer | |
| MEN1 | Endocrine, nervous system/brain, and pancreatic cancer | |
| MET | Renal/urinary tract cancer | |
| MITF | Melanoma | |
| MLH1 | Colorectal, gastric, gynaecologic, nervous system/brain, pancreatic, prostate, and renal/urinary tract cancer | |
| MSH2 | Colorectal, gastric, gynaecologic, nervous system/brain, pancreatic, prostate, and renal/urinary tract cancer | |
| MSH3 | Colorectal cancer, includes reporting of carrier status | |
| MSH6 | Colorectal, gastric, gynaecologic, nervous system/brain, pancreatic, prostate, and renal/urinary tract cancer | |
| MUTYH | Colorectal cancer | |
| NBN | Breast and prostate cancer | |
| NF1 | Breast, endocrine, gastric, and nervous system/brain cancer | |
| NF2 | Nervous system/brain cancer | |
| NTHL1 | Colorectal cancer, includes reporting of carrier status | |
| PALB2 | Breast and pancreatic cancer | |
| PDGFRA | Gastric cancer, sarcoma | |
| PMS2 | Colorectal, gastric, gynaecologic, nervous system/brain, pancreatic, prostate, and renal/urinary tract cancer | |
| POLD1 | Colorectal cancer | |
| POLE | Colorectal cancer | |
| PRKAR1A | Endocrine and nervous system/brain cancer, sarcoma | |
| PTCH1 | Nervous system/brain and skin cancer, sarcoma | |
| PTEN | Breast, colorectal, endocrine, gynaecologic, nervous system/brain and, renal/urinary tract cancer, melanoma | |
| RAD51C | Breast and gynaecologic cancer | |
| RAD51D | Breast and gynaecologic cancer | |
| RB1 | Melanoma, retinoblastoma, sarcoma | |
| RET | Endocrine cancer | |
| SDHA | Endocrine and gastric cancer, sarcoma | |
| SDHAF2 | Endocrine cancer | |
| SDHB | Endocrine, gastric, and renal/urinary tract cancer, sarcoma | |
| SDHC | Endocrine, gastric, and renal/urinary tract cancer, sarcoma | |
| SDHD | Endocrine, gastric, and renal/urinary tract cancer, sarcoma | |
| SMAD4 | Colorectal, gastric, and pancreatic cancer | |
| SMARCA4 | Gynaecologic cancer | |
| SMARCB1 | Nervous system/brain and renal/urinary tract cancer | |
| STK11 | Breast, colorectal, gastric, gynaecologic, and pancreatic cancer | |
| TMEM127 | Endocrine cancer | |
| TP53 | Breast, endocrine, gastrointestinal, genitourinary, gynaecologic, hematologic, nervous system/brain, and skin cancer, sarcoma | |
| TSC1 | Nervous system/brain, pancreatic, and renal/urinary tract cancer | |
| TSC2 | Nervous system/brain, pancreatic, and renal/urinary tract cancer | |
| VHL | Endocrine, nervous system/brain, pancreatic, and renal/urinary tract cancer | |
| WT1 | Renal/urinary tract cancer |
Cardiovascular Genetic Testing
The panel determines whether you are at an increased risk to develop more than 45 inherited conditions, including:
- Aortopathies
- Arrhythmias
- Cardiomyopathies
- Genetic forms of high blood pressure and
high cholesterol - Thrombophilia
- Additional hereditary cardiovascular conditions
The full list of genes tested for and their related condition is below:
| Gene(s) | Condition(s) | |
| ACTA2 | Aortopathy | |
| ACTC1 | Cardiomyopathy, congenital heart disease | |
| ACTN2 | Arrhythmia, cardiomyopathy | |
| ACVRL1 | Hereditary hemorrhagic telangiectasia, pulmonary arterial hypertension | |
| APOB | Familial hypercholesterolemia, familial hypobetalipoproteinemia | |
| BAG3 | Cardiomyopathy, neuromuscular condition | |
| BMPR2 | Pulmonary arterial hypertension | |
| CACNA1C | Arrhythmia, cardiomyopathy, congenital heart disease | |
| CACNB2 | Arrhythmia | |
| CALM1 | Arrhythmia | |
| CALM2 | Arrhythmia | |
| CALM3 | Arrhythmia | |
| CASQ2 | Arrhythmia, includes reporting of carrier status | |
| CAV1 | Pulmonary arterial hypertension | |
| CAV3 | Arrhythmia, cardiomyopathy, neuromuscular condition | |
| COL3A1 | Aortopathy | |
| CRYAB | Cardiomyopathy, neuromuscular condition | |
| CSRP3 | Cardiomyopathy | |
| DES | Arrhythmia, cardiomyopathy, neuromuscular condition | |
| DMD | Cardiomyopathy, neuromuscular condition | |
| DSC2 | Arrhythmia, cardiomyopathy | |
| DSG2 | Arrhythmia, cardiomyopathy | |
| DSP | Arrhythmia, cardiomyopathy | |
| EMD | Arrhythmia, cardiomyopathy, neuromuscular condition | |
| ENG | Hereditary hemorrhagic telangiectasia, pulmonary arterial hypertension | |
| F2 | Hereditary thrombophilia | |
| F5 | Hereditary thrombophilia | |
| F9 | Hemophilia, hereditary thrombophilia | |
| FBN1 | Aortopathy | |
| FHL1 | Cardiomyopathy, neuromuscular condition | |
| FLNC | Cardiomyopathy, neuromuscular condition | |
| GDF2 | Hereditary hemorrhagic telangiectasia | |
| GLA | Cardiomyopathy, lysosomal storage disease | |
| GPD1L | Arrhythmia | |
| HCN4 | Arrhythmia, cardiomyopathy | |
| JUP | Arrhythmia, cardiomyopathy | |
| KCNE1 | Arrhythmia | |
| KCNE2 | Arrhythmia | |
| KCNH2 | Arrhythmia | |
| KCNJ2 | Arrhythmia | |
| KCNQ1 | Arrhythmia | |
| LAMP2 | Cardiomyopathy, glycogen storage disease | |
| LDLR | Familial hypercholesterolemia | |
| LDLRAP1 | Familial hypercholesterolemia, includes reporting of carrier status | |
| LMNA | Arrhythmia, cardiomyopathy, neuromuscular condition | |
| MYBPC3 | Cardiomyopathy | |
| MYH11 | Aortopathy | |
| MYH7 | Cardiomyopathy, neuromuscular condition | |
| MYL2 | Cardiomyopathy | |
| MYL3 | Cardiomyopathy | |
| MYLK | Aortopathy | |
| NKX2-5 | Arrhythmia, congenital heart disease | |
| PCSK9 | Familial hypercholesterolemia | |
| PKP2 | Arrhythmia, cardiomyopathy | |
| PLN | Arrhythmia, cardiomyopathy | |
| PRKAG2 | Arrhythmia, cardiomyopathy | |
| PRKG1 | Aortopathy | |
| PROC | Hereditary thrombophilia | |
| PROS1 | Hereditary thrombophilia | |
| RBM20 | Arrhythmia, cardiomyopathy | |
| RYR2 | Arrhythmia, cardiomyopathy | |
| SCN5A | Arrhythmia, cardiomyopathy | |
| SERPINC1 | Hereditary thrombophilia | |
| SGCD | Cardiomyopathy, neuromuscular condition | |
| SMAD3 | Aortopathy | |
| SMAD4 | Hereditary hemorrhagic telangiectasia | |
| TCAP | Cardiomyopathy, neuromuscular condition | |
| TGFB2 | Aortopathy | |
| TGFB3 | Aortopathy, arrhythmia, cardiomyopathy | |
| TGFBR1 | Aortopathy, multiple self-healing squamous epithelioma | |
| TGFBR2 | Aortopathy | |
| TMEM43 | Arrhythmia, cardiomyopathy | |
| TNNC1 | Cardiomyopathy | |
| TNNI3 | Arrhythmia, cardiomyopathy | |
| TNNT2 | Arrhythmia, cardiomyopathy | |
| TPM1 | Cardiomyopathy | |
| VCL | Cardiomyopathy |
Combined Genetic Testing
When we test for cancer and cardiomyopathy combined we also screen for the following metabolic disorders:
| Gene(s) | Condition(s) | |
| ATP7B | Wilson disease, includes reporting of carrier status | |
| CACNA1S | Hypokalemic periodic paralysis, malignant hyperthermia susceptibility | |
| HAMP | Hereditary hemochromatosis, includes reporting of carrier status | |
| HFE | Hereditary hemochromatosis, includes reporting of carrier status | |
| HJV | Hereditary hemochromatosis, includes reporting of carrier status | |
| OTC | Ornithine transcarbamylase deficiency | |
| RYR1 | Malignant hyperthermia susceptibility, neuromuscular condition | |
| SERPINA1 | Alpha-1 antitrypsin deficiency, includes reporting of carrier status | |
| SLC40A1 | Hereditary hemochromatosis | |
| TFR2 | Hereditary hemochromatosis, includes reporting of carrier status |